LOS ANGELES, Jan. 08, 2026 (GLOBE NEWSWIRE) — AXIL Brands, Inc. (“AXIL,” “we,” “us,” “our,” or the “Company”) (NYSE American: AXIL), an emerging global consumer products company for AXIL® hearing protection and enhancement products and Reviv3® hair and skin care products, today announced financial and operational results for the second quarter ended November 30, 2025 (2Q26). Financial Highlights (Quarter Ended November 30, 2025)Net sales increased to $8.1 million, compared to $7.7 million in the prior year period, an increase of 5.2% Gross profit of $5.5 million, or 68.1% of sales, compared to $5.5 million, or 71.1% in the prior year period Operating expenses declined to $4.6 million, or 57.0% of net sales compared to $4.8 million, or 62.4% of net sales in the prior year period Net income increased to $704,833, compared to $633,706...

MINNEAPOLIS, Jan. 08, 2026 (GLOBE NEWSWIRE) — Northern Technologies International Corporation (NASDAQ: NTIC), a leading developer of corrosion inhibiting products and services, as well as bio-based and biodegradable polymer resin compounds, today reported its financial results for the first quarter of fiscal 2026. First quarter fiscal 2026 financial and operating highlights include (with growth rates on a fiscal quarter year-over-year basis):Consolidated net sales increased 9.2% to a quarterly record of $23,309,000 ZERUST® industrial net sales increased 6.9% to a quarterly record of $14,923,000 ZERUST® oil and gas net sales increased 58.1% to a first quarter record of $2,394,000 Natur-Tec® product net sales increased 2.2% to a quarterly record of $5,993,000 NTIC China net sales increased 23.5% to a quarterly record of $4,935,000 Gross...

DENVER, Jan. 08, 2026 (GLOBE NEWSWIRE) — The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a leader in the Nutritional Snacking Category, today reported financial results for the thirteen weeks ended November 29, 2025. First Quarter Summary:(1)Net sales of $340.2 million versus $341.3 million Net income of $25.3 million versus $38.1 million Earnings per diluted share (“EPS”) of $0.26 versus $0.38 Adjusted Diluted EPS(2) of $0.39 versus $0.49 Adjusted EBITDA(3) of $55.6 million versus $70.1 millionReaffirm Fiscal Year 2026(4) Outlook:Net sales expected to range between -2% and +2% year-over-year Gross margins expected to decline between 100 and 150 basis points year-over-year Adjusted EBITDA expected to range between -4% and +1% year-over-year“Our first quarter financial performance came...

Strong Performance Delivers Sales Growth, Margin Expansion and EPS ImprovementDelivered Net Sales of $1.1B, an Increase of 20% Compared to the Prior Year Delivered Operating Profit of $160M, Up 20% Compared to the Prior Year; Grew Adjusted Operating Profit to $196M, Up 24% Compared to the Prior Year Delivered Diluted EPS of $3.82, Up 14% Compared to the Prior Year; Grew Adjusted Diluted EPS to $4.69, Up 18% Compared to the Prior YearATLANTA, Jan. 08, 2026 (GLOBE NEWSWIRE) — Acuity Inc. (NYSE: AYI), (“Acuity”), a market-leading industrial technology company, delivered net sales of $1.1 billion in the first quarter of fiscal 2026 ended November 30, 2025, an increase of $192.1 million, or 20.2 percent, compared to the prior year. “We delivered strong performance in our first quarter of fiscal 2026,” stated...

Leiden, The Netherlands, January 8, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) today announced its preliminary, unaudited revenues for the full year 2025 and plans to host a virtual Investor Day on February 3, 2026, at 10:00 am EST (16:00 CET). Total 2025 revenues are estimated to be approximately US$376 million*, exceeding the upwardly revised guidance range of US$365 to US$375 million provided in November 2025 and representing approximately 27% growth versus 2024. This strong performance reflects continued growth of RUCONEST® and rising demand for Joenja®, driven primarily by patient uptake in the U.S. and supported by ongoing geographic expansion. Full-year 2025 operating expenses are expected to be within the previously communicated range of US$304 to US$308 million, underscoring...

Launched VIZZ™ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-November 2025 Achieved approximately $1.6 million in net product revenue with over 20,000 prescriptions filled in Q4 2025 Over 6,500 unique ECPs prescribed VIZZ; more than 55% have prescribed multiple times in Q4 2025 SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmic solution) 1.44%, the first and only aceclidine-based eye drop for the treatment of presbyopia, today reported certain preliminary unaudited financial results for the fourth quarter ended December 31, 2025 and recent corporate updates. “We are proud of the strong...

DALLAS, Jan. 07, 2026 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial intelligence, cloud, networking and blockchain workloads, reported financial results for the fiscal second quarter ended November 30, 2025. The Company also provided operational updates. Fiscal Second Quarter 2026 Continuing Operations Financial HighlightsRevenues: $126.6 million, up 250% from the prior year comparable period Net loss attributable to common stockholders: $31.2 million, down 76% from the prior year comparable period Net loss attributable to common stockholders per basic and diluted share: $0.11, down 82% from the prior year comparable period Adjusted...

WILMINGTON, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (“UniFirst” or the “Company”) today reported results for its fiscal 2026 first quarter ended November 29, 2025. First Quarter 2026 Consolidated ResultsConsolidated revenues increased 2.7% to $621.3 million compared to $604.9 million in the first quarter of fiscal 2025, driven by organic growth in the core Uniform & Facility Service Solutions segment. Operating margin was 7.3% compared to 9.2% in the prior year period, reflecting planned investments in growth and digital transformation initiatives. Net income was $34.4 million compared to $43.1 million in the prior year period and diluted earnings per share was $1.89 compared to $2.31 in the prior year period. Adjusted EBITDA margin was 13.3% compared to 15.5% in the prior year period. The...

RIDGELAND, Miss., Jan. 07, 2026 (GLOBE NEWSWIRE) — Cal-Maine Foods, Inc. (NASDAQ: CALM) (“Cal-Maine Foods,” “we,” “us,” “our” or the “company”), the largest egg company in the United States and a leading player in the egg-based food industry, today reported results for its fiscal 2026 second quarter, ended November 29, 2025. Unless otherwise indicated, all comparisons are to the comparable period of fiscal 2025. Strategic Execution HighlightsContinued focus on sales diversification and mix shift, expected to strengthen earnings durability and predictability over timeIn the second quarter of fiscal 2026Shell egg sales represented 84.4% of total net sales, down 1,030 basis points Specialty eggs drove a greater portion of shell egg sales, accounting for 44.0% of total shell egg sales, up 1,230 basis points Specialty eggs and...

HARVEST VOLUMES OF SALMON AND TROUT Total harvest volume of salmon and trout for Q4 2025 was 49,300 GWT, compared to 56,800 GWT in Q4 2024. For the full year 2025, harvested volume of salmon and trout was 195,600 GWT compared to 171,200 GWT in 2024. These figures exclude harvest volumes from Scottish Seafarms. Harvest volumes by region/company for Q4 2025 (Q4 2024), measured in 1,000 GWT: Lerøy Aurora: 16.4 (15.4) Lerøy Midt: 16.2 (22.6) Lerøy Sjøtroll: 16.8 of which 7.9 was trout (18.8 of which 8.2 was trout) CATCH VOLUMES OF WILDFISH Total wild catch volumes in Lerøy Havfisk, measured in 1,000 tonnes: Q4 2025: 7.6 of which 2.7 of cod Q4 2024: 9.8 of which 3.1 of cod The catch volume for 2025 was 57,700 tonnes compared to 65,000 tonnes in 2024.  The complete Q4 2025 report will be released on 24 February at 06:30 CET. Queries may be addressed...